Zacks Investment Research
05 Nov 2026, 01:52 UTC · 14m ago
OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates
Impact · against what's priced in
OPKO Health's Q3 results show a significant deterioration in fundamentals, marked by a 56.9% year-over-year revenue collapse. While the company beat a low earnings estimate, the massive revenue miss suggests a fundamental decline in the business that outweighs the minor EPS surprise.
- OPK−0.60
No priced-in read yet
- In context
Revenues of $65.4 million missed estimates by nearly 52% and dropped 56.9% from the prior year's $151.7 million, indicating a severe contraction in business scale.
Read from the article alone
Search tags
